AtriCure Inc at Morgan Stanley Global Healthcare Conference Transcript
Good afternoon. Thank you for joining us for the second day of the Morgan Stanley Healthcare Conference. I'm Cecilia Furlong, medical device analyst here at Morgan Stanley. It's my pleasure to have AtriCure with us, CEO, Mike Carrel. Thank you, again, for being here with us.
Great to be here. Thanks for having us.
Questions & Answers
And really quickly, disclosures, see www.morganstanley.com/disclosures. But with that, I wanted to start with the macro, what you've seen in terms of staffing, other dynamics in your business. And then could you speak to I think we've had some questions in terms of CONVERGE specifically, and I want to spend some time on that. But what have been the biggest challenges as you think about just bringing this procedure up during COVID? There are a lot of logistical challenges
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |